(Q61868345)
Statements
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group (English)
U Rath
I Olver
E Van Cutsem
C Svensson
J F Seitz
P Harper
D Kerr
1 November 1995